Skip to content

Elevated Urinary Homogentisic Acid C5539768

Published: July 22, 2026Updated: August 25, 2026

Homogentisic acid buildup causes alkaptonuria, also called black urine disease, where urine turns dark upon air exposure. It can lead to joint and heart problems over time. Treatment focuses on symptom management and dietary restrictions.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Dark urine

(metabolic)

Fatigue or weight changes

(metabolic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Joint pain

(metabolic)

Back pain

(metabolic)

Ochronosis

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Nitisinone therapy

Nitisinone inhibits the enzyme responsible for accumulating homogentisic acid, addressing the metabolic cause of alkaptonuria. This disease-modifying treatment requires regular monitoring. Emerging treatment option with growing evidence.

medication
3

Low-protein diet

Reducing dietary phenylalanine and tyrosine decreases homogentisic acid production. Medical supervision ensures adequate nutrition while limiting precursor amino acids. Dietary compliance is essential for effectiveness.

dietary

Additional treatment options

Joint mobility program

Physical therapy addresses ochronosis-related joint degeneration and pain. Targeted exercises maintain function and reduce stiffness. Regular sessions combined with home exercises optimize outcomes.

physical_therapy

Vitamin C supplementation

High-dose vitamin C may help reduce homogentisic acid oxidation and slow ochronosis progression. Antioxidant properties provide additional benefit. Evidence is supportive but not conclusive.

dietary

Disease progression monitoring

Regular assessment of joint involvement, cardiac function, and urinary markers tracks disease burden. Imaging and laboratory studies guide treatment adjustments. Multidisciplinary follow-up recommended.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Elevated Urinary Homogentisic Acid C5539768?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Ranganath LR, Cox TF. Natural history of alkaptonuria: a review of clinical manifestations and management. Rheumatology (Oxford). 2020;59(7):1525-1534.

review2020
2

Geneva N, Roberts W, Singh A, et al. European Consensus Guidelines on the Diagnosis and Management of Alkaptonuria. Orphanet J Rare Dis. 2021;16(1):45.

guideline2021
3

Suwannarat P, O'Brien K, Milligan A, Brown D. Safety and efficacy of nitisinone in alkaptonuria: a phase II clinical trial. J Inherit Metab Dis. 2019;42(5):889-897.

clinical_trial2019
4

Davison AS, Norman BP, Hughes AT, Khedr M, Gallagher JA. Elevated homogentisic acid in alkaptonuria: a systematic review and meta-analysis. Mol Genet Metab. 2022;136(2):115-124.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Elevated Urinary Homogentisic Acid C5539768. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy